RE:RE:RE:When will the bleeding stop?Hi Ron.
These share prices represent a huge buying opportunity. I'm long and accumulating as I have the resources. Ever since July of 2013 there has not been one step backwards. It has been nothing but
continuous scientific progress. Yes it is true that trial design has been a serious problem in the past such as underpowering the ASSURE trial and using PAV as an endpoint. In fact, had the study been properly powered the PAV target may have been met with time.
But that is hind sight. It is easy for any armchair QB to criticise it. But knowledge is progressive and we know that rvx-208 has not been abandoned.
From what I see the big money continues to flow in and there will be more partners. Also, the scientific momentum continues in terms of the number, experience and influence of very high profile doctors and scientists in DM,CVD, CKD.and other inflammatory diseases..all highly related diseases.
I'm not a trading expert and I yet I know there are many investors with varying objectives...and that is great. I sense that there are many investors just sitting on the sidelines who will watch the milestones through the trial and start investing when the shares hit $3.00 and then $5.00 and then $10.00 and on and on because at the right point even coming in at $10.00 they know the money to be made. Various traders will make big dollars along the way but the real money will be in the CVR deal - initial payout, milestone payouts, successful trial payout and then the ongoing royalties. That is my target.
So consider the declining share price as a big positive...we all know what is coming.
Cheers from
Toinv :)
- Alias - hoity toity, fraudster, liar, humper, dumper, pumper, lumper and whatever other nonsense he/she/it calls me.